

Matt Lanktree | #NephroGenetics
3K posts

@MattLanktree
Clinician Scientist in Nephrology Genetics @McMasterU @StJoesHamilton @PHRIresearch













Cardiometabolic therapies have deepest impact in those with highest risk. In the CORE trials, pts with sHTG ≥ 880 mg/dL + prior AP saw >80% fewer acute pancreatitis events with olezarsen, a transformative ARR 32.5% in 1 yr (NNT ≈ 4!). #AHA25





























Clonal hematopoiesis (CH, blood stem cells with mutations) is considered a risk factor for cardiovascular disease and other adverse health outcomes. But today we learn about its potential benefit vs Alzheimer's disease sciencedirect.com/science/articl…






New evidence today @NEJM that age-related clonal hematopoiesis (CHIP) has a driver role in evolution of solid cancers nejm.org/doi/full/10.10… nejm.org/doi/full/10.10…



